Brown & Brown Inc:企業の戦略・SWOT・財務分析

◆英語タイトル:Brown & Brown Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5366
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Brown & Brown Inc – Strategy, SWOT and Corporate Finance Report
Summary

Brown & Brown Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Brown & Brown, Inc. (Brown & Brown) is an insurance agency. It provides a wide range of insurance products, brokerage services, and insurance programs through its subsidiaries. It offers primarily insurance products for property, casualty and employee benefits. It also offers comprehensive risk management and third-party administration. Furthermore, Brown & Brown offers services including brokerage, reinsurance, trade credit, surety bonds, wealth management and estate planning. Through these products and services, the company serves public entities, corporates, institutional, trade, association, professional, and individual customers. Brown & Brown operates in the US, Canada, England, Bermuda and the Cayman Islands. The company is headquartered in Daytona Beach, Florida, the US.

Scope

- Detailed information on Brown & Brown Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Brown & Brown Inc in the form of a SWOT analysis
- An in-depth view of the business model of Brown & Brown Inc including a breakdown and examination of key business segments
- Intelligence on Brown & Brown Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Brown & Brown Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Brown & Brown Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Brown & Brown Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Brown & Brown Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Brown & Brown, Inc.: Company Overview
Brown & Brown, Inc.: Overview and Key Facts
Brown & Brown, Inc.: Overview
Brown & Brown, Inc.: Key Facts
Brown & Brown, Inc.: Key Employees
Brown & Brown, Inc.: Key Employee Biographies
Brown & Brown, Inc.: Major Products and Services
Brown & Brown, Inc.: Company History
Brown & Brown, Inc.: Management Statement
Brown & Brown, Inc.: Locations and Subsidiaries
Brown & Brown, Inc.: Key Competitors
Brown & Brown, Inc.: Company Analysis
Brown & Brown, Inc.: Business Description
Brown & Brown, Inc.: SWOT Analysis
Brown & Brown, Inc.: SWOT Overview
Brown & Brown, Inc.: Strengths
Brown & Brown, Inc.: Weaknesses
Brown & Brown, Inc.: Opportunities
Brown & Brown, Inc.: Threats
Brown & Brown, Inc.: Corporate Financial Deals Activity
Brown & Brown, Inc.: Financial Deals Overview
Brown & Brown, Inc.: Targets and Partners
Brown & Brown, Inc.: Top Deals 2016 – 2020YTD*
Brown & Brown, Inc.: Mergers and Acquisitions
Brown & Brown, Inc.: Recent Developments
Brown & Brown, Inc.: News and Events Summary
Brown & Brown, Inc.: Contracts
Brown & Brown, Inc.: Corporate Governance
Brown & Brown, Inc.: Financial Deals
Brown & Brown, Inc.: Financial Performance
Brown & Brown, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Brown & Brown, Inc.: Key Facts
Table 2: Brown & Brown, Inc.: Key Employees
Table 3: Brown & Brown, Inc.: Company History
Table 4: Brown & Brown, Inc.: Locations and Subsidiaries
Table 5: Brown & Brown, Inc.: Key Competitors
Table 6: Brown & Brown, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Brown & Brown, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Brown & Brown, Inc.: Targets and Partners
Table 9: Brown & Brown, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Brown & Brown, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Brown & Brown, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 12: Brown & Brown, Inc.: News and Events Summary
Table 13: Brown & Brown, Inc.: Contracts
Table 14: Brown & Brown, Inc.: Corporate Governance
Table 15: Brown & Brown, Inc.: Financial Deals
Table 16: Brown & Brown, Inc.: Financial Performance
Table 17: Brown & Brown, Inc.: Strategy and Operations

★海外企業調査レポート[Brown & Brown Inc:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Promimic AB-医療機器分野:企業M&A・提携分析
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets implant surface modifications and synthetic bones. The company’s products comprise metals, ceramics, polymers, porous materials and pyrocarbon. Its HA-nano surface is a coating based on nanocrystalline hydroxyapatite p …
  • Octapharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical …
  • Winpak Ltd.:企業の戦略・SWOT・財務情報
    Winpak Ltd. - Strategy, SWOT and Corporate Finance Report Summary Winpak Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Qiagen NV (QIA):医療機器:M&Aディール及び事業提携情報
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company offers consumable products, instruments and automation systems. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify …
  • OUTsurance Holdings Limited:企業の戦略・SWOT・財務情報
    OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary OUTsurance Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastroint …
  • Telecom Plus plc (TEP):電力:M&Aディール及び事業提携情報
    Summary Telecom Plus plc (Telecom Plus), trading as The Utility Warehouse, is a provider of utility services. It supplies basic utilities such as energy, home phone, broadband and mobile services, and provides the bill of the services in a single monthly statement. Its services include fixed and mob …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mitsubishi Electric Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Shinko Electric Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • RegenxBio Inc (RGNX):企業の財務・戦略的SWOT分析
    RegenxBio Inc (RGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Clarius Group Limited (CND):企業の財務・戦略的SWOT分析
    Clarius Group Limited (CND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nexira:企業の戦略・SWOT・財務情報
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Helijet International Inc.:企業の戦略・SWOT・財務分析
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • LCH.Clearnet Group Limited:企業の戦略・SWOT・財務情報
    LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report Summary LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Prysmian S.p.A.:企業の戦略・SWOT・財務情報
    Prysmian S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Prysmian S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kier Group plc:企業のM&A・事業提携・投資動向
    Kier Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kier Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Sequella Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sequella Inc (Sequella) is a clinical-stage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company’s pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, B-SMART. S …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆